首页
登录
职称英语
A personalized blood test that can identify tumor(肿瘤)DNA could be the first
A personalized blood test that can identify tumor(肿瘤)DNA could be the first
游客
2024-04-30
22
管理
问题
A personalized blood test that can identify tumor(肿瘤)DNA could be the first step towards a long-promised revolution in the way cancer is treated.
In the short term, the test—reported by Victor Velculescu of Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland, and his colleagues in Science Translational Medicine—could be used to spot cancer recurrence before tumor growth shows up on scans, meaning that treatment could be started earlier.
The test detects genetic rearrangements that distinguish cancer cells from normal cells. Eventually it might also pave the way for more personalized cancer treatments tailored to the genetic signature of individuals’ tumors.
Doctors already classify cancers by some of the genes that get switched on by the disease, and use this to guide treatment in some cases. For example, breast cancers are often divided into those that express oestrogen(雌激素)receptors on their surface and are therefore likely to respond to the drug tamoxifen(三苯氧胺), and those that don’t.
Genes have also been identified that predict whether a variety of cancers are resistant to radiotherapy and certain drugs, and might therefore need a different sort of treatment. It is also possible to stratify(使分层)cancers into aggressive and non-aggressive subtypes(类型)according to their genetic make-up.
But that’s just the beginning. In the future, pretty much all cancers are likely to be defined by the genetic pathways that drive their growth, rather than where in the body they manifest themselves. And because cancers mutate as they grow, it should be possible to track these changes and tailor patients’ therapies accordingly.
Velculescu’s test is a step towards this. The real breakthrough will come when such blood tests become sophisticated enough to reveal how tumors are changing over time, rather than simply spotting that they have come back. That should truly revolutionize cancer treatment, enabling the most effective combinations of drugs to be tailored to individual patients—and without the need for painful tissue biopsies(生检采样). [br] If the blood test technique gets matured, we can see how______.
选项
答案
tumors are changing over time
解析
本题考查该血液检测技术成熟后的结果。根据定位句可知,这项血液检测技术成熟后,可揭示肿瘤变化的过程,而这将是真正的突破。题干中的gets matured是原文中的become sophisticated的同义转述,题干要求将主句补允完整,而原句中when such blood tests become sophisticated enough对应的结果是动词不定式短语to reveal how turnouts are changing over time,因此根据题干语法要求,可知该短语中how所引导的宾语从句的内容tumors are changing over time是本题答案。
转载请注明原文地址:https://www.tihaiku.com/zcyy/3577810.html
相关试题推荐
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
随机试题
WhomostlikelyisAlexHawkins?[br][originaltext]Hello,everyone.ThisisAl
Whatdoyouknowaboutthewomanspeaker?[originaltext]W:Hello,Stall.Comein
They____________(得出这一结论)thatitwillbecheaperinthelongruntousereallea
安济桥坐落在北京的永定河上。( )
急性心肌梗死发生左心衰竭的主要原因是A.室性期前收缩 B.房室传导阻滞 C.
《中华人民共和国公司法》规定,公司的剩余资产在分配给股东之前,其支付顺序为()。
下列说法中,正确的是()。 A.证券包销是指证券承销商将发行人的证券按
已发行的证券在证券交易所上市前,证券发行人应当在中国结算公司规定的时间内申请办理
下列何种修复方法不属于牙体缺损的修复A:嵌体 B:金属全冠 C:套筒冠 D
女,50岁,高热,寒战5天,意识模糊1天。既往体健。查体:T39℃,P120
最新回复
(
0
)